Novacyt Investor Presentation 2017

Novacyt is a diagnostic testing company specializing in oncology and infectious disease with proprietary technologies and strong gross margins near 60%. The presentation outlines the company's IPO plans for 2017 and highlights growth opportunities in a large, fragmented market with significant M&A potential.